Cytokinetics (CYTK) PT Lowered to $55 at JPMorgan
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $70.71 -0.28%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JPMorgan analyst Tessa Romero lowered the price target on Cytokinetics (NASDAQ: CYTK) to $55.00 (from $64.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nomura/Instinet Downgrades ORIX Corp (8591:JP) (IX) to Neutral
- Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
